Treating influenza with zanamivir (multiple letters) [1]

Lancet

Volumn 353, Issue 9153, 1999, Pages 668-669

  Fleming, D M ^a   Read, R C ^a   Silagy, C A ^a  

^a Northfield Health Centre   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMANTADINE; RIMANTADINE; ZANAMIVIR;

DOSE TIME EFFECT RELATION; DRUG EFFICACY; DRUG RESISTANCE; HIGH RISK POPULATION; HUMAN; INFLUENZA; INHALATIONAL DRUG ADMINISTRATION; LETTER; PRIORITY JOURNAL; TOPICAL DRUG ADMINISTRATION; VIRUS MUTANT;

EID: 0032984451     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(99)00033-1     Document Type: Letter

References (5)

1. Hayden FG Albert DME Osterhaus DVM Efficacy and safety of the neuraminidase inhibitors zanamivir in the treatment of influenza virus infections NEngl J Med 337 1997 874 880
2. Hayden FG Treanor JJ Betts RF Lobo M Esinhart JD Hussey EK Safety and efficacy of the neuraminidase inhibitor GG/67 in experimental human influenza JAMA 275 1996 295 299
3. Recent increases in influenza and other respiratory infections Comm Dis Rep 9 1999 17 20
4. Schilling M Povinelli L Krause P Efficacy of zanamivir for chemoprophylaxis of nursing home influenza outbreaks Vaccine 16 1998 1771 1774
5. Gubareva LV Matrosovich MN Brenner MK Bethell RC Webster RC Evidence for zanamivir resistance in an immunocompromised child infected with influenza B virus J Infect Dis 178 1998 1257 1262